Ozempic® for $299/month

Doctor-guided weight loss with Authentic medication

Three Steps to Start, A Lifetime of
Partnered Wellness Ahead.

Because every body is different, your refill schedule should be, too. Get unlimited provider access and order medication only when you feel it’s time – never on a rigid auto-ship cycle.

Activate Your Wellness Membership

Sign up for our wellness membership and unlock unlimited access to our Florida-licensed care team. Right after checkout you’ll get a secure link to schedule your first telehealth visit whenever it suits you.

Expert Consultation

RN and our prescribing clinician. Together you’ll review your health history, choose the right GLP-1 option, fine-tune dosage, and set realistic milestones – with unlimited follow-ups included.

Refill on Your Schedule

Log in and tap Order Refill whenever you’re ready. Your active membership unlocks transparent member pricing; you choose the timing and quantity. Meds ship in temperature-controlled packaging with real-time tracking – no forced auto-shipments, ever.

Your Body, Your Terms

Semaglutide for Losing Weight | Tirzepatide for Losing Weight | Long Term Weight Loss

ZenFit Wellness Membership

billed every one months

$75 /mo + medication

Unlimited provider & dietitian check-ins
Direct access to a Florida-licensed clinician
Personal roadmap, not a template
Transparent, affordable medication pricing
Refill on your clock
No hidden fees. Cancel anytime.

Access to Exclusive Member Pricing

Traditional Diets

No medical oversight

Generic advice

May not account for medical and biological conditions

Unsustainable for long-term

How ZenFit Compare to Other Telehealth
Weight-Loss Services

We provide only genuine, brand-name GLP-1 medications — trusted for safety, proven for results, and prescribed by licensed professionals.

Features	ZenFit Wellness	Ro (ro.co)	Hims (forhims.com)
Authentic GLP-1 Medications	✔	✔	✖
Ozempic Available	✔	✖	✖
Simple $299/Month Pricing	✔	✖	✖
Mandatory Membership Fees $75/month	✔	✖	✖
Provider-Reviewed Medical Intake	✔	✔	✔
Ship Directly to your Doorsteps!	✔	✖	✖
Transparent, All-Inclusive Pricing	✔	✖	✖
Best for Cash-Pay Patients	✔	✖	✖

Direct Self-Pay Options vs ZenFit Wellness

We provide only genuine, brand-name GLP-1 medications — trusted for safety, proven for results, and prescribed by licensed professionals.

Novo Nordisk Direct Program:

Offers self-pay access to Ozempic and Wegovy at approximately $499/month. Insurance savings cards are available for eligible patients, but cash-pay patients may still face high costs.

Eli Lilly Direct Program:

Offers self-pay access to Zepbound via LillyDirect, also around $499/month for certain vial strengths. Savings cards are available for insured patients, but costs for cash-pay patients remain significant.

ZenFit Wellness Products

ZenFit Wellness Club blends fitness, mindfulness, and wellness to help you feel stronger, calmer, and more energized every day.

Shipping Included

Ozempic (Semaglutide)

Monthly Quarterly

$399/month

$299/month

Your weight loss questions, answered.

Navigate the Noise: Get Clear on GLP-1 Treatments Like Semaglutide, Tirzepatide, Ozempic®, Wegovy®, Mounjaro®, and Zepbound™.

What medications do you offer?

We currently provide Ozempic (semaglutide) and Mounjaro/Zepbound (tirzepatide) only.

How does the process work?

Complete the online medical intake, our provider reviews your case, and if approved, your prescription is sent to our pharmacy partner for direct home delivery.

How much does it cost?

You pay a monthly service fee to us and a separate medication cost to our fulfillment partner. We provide full transparent pricing with no hidden fees.

Are the medications authentic?

Yes — we only supply authentic, brand-name medications, sourced through a licensed international pharmacy partner and shipped directly to your home.

The information provided about GLP-1 treatments and their efficacy is based on findings from the study: “Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review.” Published in Advances in Therapy, May 2022. DOI: 10.1007/s12325-022-02153-x. Available online at: PubMed Central.